Chimerix
Latest round
- Series F
Last raised
- Feb 2011
Total raised
- $102M
Investors
- 8
About Chimerix
Chimerix, Inc.Founded in 2002 and headquartered in Durham, US, Chimerix, Inc. specializes in the development of pharmaceuticals aimed at oncology.87 million in a public offering in October 2013.38 mn.Chimerix specializes in developing innovative medicines targeting cancer and other serious diseases, positioned under the oncology sector. The company's core product offerings primarily include imipridones, with notable compounds such as ONC201, ONC206, and ONC212, designed to address various types of tumors, including gliomas and central nervous system tumors. These imipridones function by leveraging unique mechanisms to inhibit tumor growth and promote cancer cell death, thereby providing potential therapeutic solutions for patients.Chimerix generated USD 212,000 in revenue for the most recent fiscal year 2024, with an EBITDA of USD -93,001,000. Its revenue model primarily involves partnerships with healthcare providers and research organizations, facilitating access to its pharmaceutical offerings through direct B2B agreements for clinical use and expanded access programs.Chimerix plans to further develop its imipridone compounds and is exploring new therapeutic areas within oncology. The company is targeting expanded market presence in specific regions of Europe by 2025.
Who invested in Chimerix
8 investors across 7 rounds
See all investors in Chimerix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Feb 14, 2011
Amount
$45M
Investors
Series E
Jul 24, 2009
Amount
$16M
Investors
Series D
Feb 23, 2007
Amount
$23M
Investors
Series C
Jul 7, 2006
Amount
$1.5M
Investors
Series C
Nov 4, 2004
Amount
$11M
Investors
Series B
Sep 8, 2003
Amount
$3.1M
Investors
Series A
Jul 1, 2002
Amount
$2.2M
Investors
Questions about Chimerix
Who invested in Chimerix?
Chimerix has 8 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chimerix raised?
Chimerix has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Chimerix last raise money?
Chimerix's most recent round on record is a Series F, in Feb 2011.
What does Chimerix do?
Chimerix is a biotechnology company.
Where is Chimerix headquartered?
Chimerix is headquartered in Durham, US.
Which VCs invest in companies like Chimerix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Chimerix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Chimerix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.